COVID-19-related changes in outpatient CPAP setup pathways for OSA are linked with decreased 30-day CPAP usage. Issue 8 (9th May 2022)

• Record Type: Journal Article
• Authors: Turnbull, Chris D; Allen, Martin; Appleby, Jennifer; Brown, Richard; Bryan, Nathalie; Cooper, Ann; Cooper, Brendan G; Gillooly, Cathie; Davidson, James; Farley, Hannah; Gaspar, Ana; Gibbons, Gillian; Gray, Beverley; Hill, Graham; Kendrick, Adrian; Marsh, Blake; McMillan, Alison; Page, Joseph; Pepperell, Justin Charles Thane; Quinnell, Tim; Rogers, Chris; Sexton, Jane; Sheperd, Naomi; Steier, Joerg; Stockley, James; Stradling, John; Woroszyl, Asia; West, Sophie; Wright, Susan; Nickol, Annabel
• Is Part Of: Thorax. Volume 77:Issue 8(2022)
• Page Start: 839
• Page End: 841
• Publication Date: 2022-05-09
• Subjects: COVID-19 -- Sleep apnoea -- Non invasive ventilation; Chest -- Diseases -- Periodicals; Thorax; Chest -- Diseases; Periodicals; Periodicals; 617.54
• DOI: 10.1136/thoraxjnl-2021-218635
• Languages: English
• ISSNs: 0040-6376

Abstract

Abstract : The COVID-19 pandemic changed continuous positive airway pressure (CPAP) setup pathways. We evaluated patients commenced on CPAP in 2019 (prepandemic) and 2020 (post-first UK wave). Face-to-face (F2F) setup numbers, with CPAP turned on, decreased from 613 patients (98.9%) in 2019, to 6 (1.1%) in 2020. In 2020, setups were F2F without CPAP turned on (403 (71.1%)), or remote (158 (27.9%)). Prepandemic median CPAP usage at first follow-up was 5.4 (2.7–6.9) hours/night and fell by 0.9 hours/night (95% CI 0.5 to 1.2, p<0.0001) in 2020. We found clinically relevant reductions in CPAP usage with pathway changes post-COVID-19.